Prognostic significance of MUC1, MUC2 and MUC5AC expressions in gastric carcinoma

Turkish Journal of Gastroenterology

Volumn 21, Issue 4, 2010, Pages 345-352

  Ilhan, Özgür ^a   Han, Ünsal ^a   Önal, Binnur ^a   Çelik, Serkan Yaflar ^a  

^a DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Gastric carcinoma; Immunohistochemistry; MUC1; MUC2; MUC5AC; Prognosis

Indexed keywords

MUCIN 1; MUCIN 2; MUCIN 5AC;

ADULT; ARTICLE; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CARCINOMA; STOMACH EPITHELIUM; TISSUE DIFFERENTIATION;

ADENOCARCINOMA, MUCINOUS; CARCINOMA, SIGNET RING CELL; CELL DIFFERENTIATION; FEMALE; GASTRECTOMY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; MUCIN 5AC; MUCIN-1; MUCIN-2; NEOPLASM INVASIVENESS; PROGNOSIS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79951962330     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: 10.4318/tjg.2010.0119     Document Type: Article

References (31)

1. Barresi V, Vitarelli E, Grosso M, et al. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas. Eur J Histochem 2006; 50: 301-10.
2. Akyurek N, Akyol G, Dursun A, et al. Expression of MUC1 and MUC2 mucins in gastric carcinomas: their relationship with clinicopathologic parameters and prognosis. Pathol Res Pract 2002; 198: 665-74. (Pubitemid 35452874)
3. Zhang HK, Zhang QM, Zhao TH, Li YY, Yi YF. Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance. World J Gastroenterol 2004; 10: 3044-7.
4. Leteurtre E, Zerimech F, Piessen G, et al. Relationships between mucinous gastric carcinoma, MUC2 expression and survival. W J Gastroenterol 2006; 12: 3324-31. (Pubitemid 43933775)
5. Baldus SE, Zirbes TK, Engel S, et al. Correlation of the immunohistochemical reactivity of mucin cores MUC1 and MUC2 with histopathological subtype and prognosis of gastric carcinomas. Int J Cancer 1998; 79: 133-8. (Pubitemid 28201683)
6. Pinto-de-Sousa J, David L, Reis CA, et al. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation and differentiation and clinico-biological behaviour of gastric carcinoma. Virchows Arch 2002; 440: 304-10. (Pubitemid 34230736)
7. Lee HS, Lee HK, Kim HS, et al. MUC1, MUC2, MUC5AC and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators. Cancer 2001; 92: 1427-34. (Pubitemid 32947826)
8. Reis CA, David L, Carvalho F, et al. Immunohistochemical study of the expression of MUC6 mucin and co-expression of the other secreted mucins (MUC5AC and MUC2) in human gastric carcinomas. J Histochem Cytochem 2000; 48: 377-88. (Pubitemid 30131684)
9. Chen Y, Zhao YH, Kalaslavadi TB, et al. Genome-wide search and identification of a novel gel-forming mucin MUC19 in glandular tissue. Am J Respir Cell Mol Biol 2004; 30: 155-65. (Pubitemid 38147200)
10. Higuchi T, Orita T, Nakanishi S, et al. Molecular cloning, genomic structure and expression analysis of MUC20, a novel mucin protein, up-regulated in injured kidney. J Biol Chem 2004; 279: 1968-79. (Pubitemid 38084468)
11. Lightenberg MJ, Kruijshaar L, Buijs F, et al. Cell associated episialin is a complex containing two proteins derived from a common precursor. J Biol Chem 1992; 267: 6171-7.
12. Lightenberg MJ, Vos HL, Gennisen AM, Hilkens J. Episialin, a carcinoma associated mucin, is generated by a polymorphic gene encoding splice variants with alternative amino termini. J Biol Chem 1990; 265: 5573-8. (Pubitemid 20127185)
13. Reis CA, David L, Correa P, et al. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC and MUC6) expression. Cancer Res 1999; 59: 1003-7. (Pubitemid 29135958)
14. Zotter S, Hagemen PC, Lossnitzer A, et al. Tissue and tumor distribution of human polymorphic epithelial mucin. Cancer Rev 1998; 11/12: 55-101.
15. Gendler SJ, Lancester CA, Taylor-Papadimitriou J, et al. Molecular cloning and expression of human tumor associated polymorphic epithelial mucin. J Biol Chem 1990; 265: 15286-93.
16. Seregni E, Botti C, Massaron S, et al. Structure, function and gene expression of epithelial mucins. Tumori 1997; 83: 625-32. (Pubitemid 27325971)
17. Ho SB, Niehans GA, Lyftogt C, et al. Heterogeneity of mucin expression in normal and neoplastic tissues. Cancer Res 1993; 53: 641-51. (Pubitemid 23059449)
18. Ho SB, Shekels LL, Toribara NW, et al. Mucin gene expression in normal, preneoplastic and neoplastic human gastric epithelium. Cancer Res 1995; 55: 2681-90.
19. Gurbuz Y, Kahlke V, Kloppel G. How do gastric carcinoma classification systems relate to mucin expression patterns? An immunohistochemical analysis in a series of advanced gastric carcinomas. Virchows Arch 2002; 440: 505-11. (Pubitemid 34591734)
20. Wakatsuki K, Yamada Y, Narikiyo M, et al. Clinicopathological and prognostic significance of mucin phenotype in gastric cancer. J Surg Oncol 2008; 98: 124-9.
21. Hanski C, Hofmeier M, Schmitt-Graff A, et al. Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast and the ovary. J Pathol 1997; 182: 385-91. (Pubitemid 27317202)
22. Park ET, Gum JR, Kakar S, et al. Aberrant expression of SOX2 upregulates MUC5AC gastric foveolar mucin in mucinous cancers of the colorectum and related lesions. Int J Cancer 2008; 122: 1253-60. (Pubitemid 351287224)
23. O'Connell JT, Hacker CM, Barsky SH. MUC2 is a molecular marker for pseudomyxoma peritonei. Mod Pathol 2002; 15: 958-72.
24. Hamilton S, Aaltonen LA. Tumours of the stomach in World Health Organization Classification of Tumours of the Digestive System. Lyon: IARCH Press, 2000; Chapter 3; 37-66.
25. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. Acta Pathol Microbiol Scand 1965; 64: 31-49.
26. Borrmann R. Geschwülste des Magens und Duodenums. In: Henske F, Lubasch O, eds. Handbuch der Speziellen Pathologischen Antomie und Histologie. Berlin: Julius Springer, 1926.
27. Grene FL. Stomach. In: American Joint Committee on Cancer- AJCC Cancer Staging Manual. 6th ed. New York: Springer, 2002.
28. Fenoglio-Preiser C, Carneiro F, Correa P, et al. WHO histological classification of gastric tumour. In: Hamilton SR, Aaltonen LA, eds. Tumours of the Stomach in World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. Lyon: IARCH Press, 2000; Chapter 3; 37-66.
29. Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol 2003; 56: 1-9. (Pubitemid 36183309)
30. Allgayer H, Heiss MM, Schildberg FW. Prognostic factors in gastric cancer. Br J Surg 1997; 84: 1651-64. (Pubitemid 27519590)
31. Yamachika T, Inada K, FujimitsuY, et al. Intestinalisation of gastric signet ring cell carcinomas with progression. Virchows Arch 1997; 431: 103-10. (Pubitemid 27393840)